Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Indivior Pharmaceuticals (INDV) Receivables - Other (2023 - 2025)

Indivior Pharmaceuticals has reported Receivables - Other over the past 3 years, most recently at $2.0 million for Q4 2025.

  • For Q4 2025, Receivables - Other changed 0.0% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, changed 0.0%, while the annual FY2025 figure was $2.0 million, 0.0% changed from the prior year.
  • Receivables - Other for Q4 2025 was $2.0 million at Indivior Pharmaceuticals, roughly flat from $2.0 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $2.0 million in Q4 2024 and troughed at $1.0 million in Q4 2023.
  • A 3-year average of $1.7 million and a median of $2.0 million in 2024 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: surged 100.0% in 2024 and later changed 0.0% in 2025.
  • Year by year, Receivables - Other stood at $1.0 million in 2023, then surged by 100.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
  • Business Quant data shows Receivables - Other for INDV at $2.0 million in Q4 2025, $2.0 million in Q4 2024, and $1.0 million in Q4 2023.